Your browser doesn't support javascript.
loading
Influence of disease activity on RA treatment choices in countries with restricted access to expensive, innovative drugs: a discrete choice experiment among rheumatologists.
Hifinger, Monika; Hiligsmann, Mickael; Ramiro, Sofia; Watson, Verity; Berghea, Florian; Péntek, Márta; Keat, Andrew; Severens, Johan L; Fautrel, Bruno; Boonen, Annelies.
Afiliação
  • Hifinger M; CAPHRI Research Institute,Maastricht University, Maastricht, The Netherlands.
  • Hiligsmann M; Department of Rheumatology, Maastricht University Medical Center, Maastricht, The Netherlands.
  • Ramiro S; CAPHRI Research Institute,Maastricht University, Maastricht, The Netherlands.
  • Watson V; Department of Health Services Research, Maastricht University, Maastricht, The Netherlands.
  • Berghea F; Department of Rheumatology, Leiden University Medical Center, Leiden, The Netherlands.
  • Péntek M; Health Economics Research Unit,University of Aberdeen, Aberdeen, UK.
  • Keat A; Department of Rheumatology, University of Medicine and Pharmacy Carol Davila, Bucharest, Romania.
  • Severens JL; Department of Health Econmics, Corvinus University of Budapest, Budapest, Hungary.
  • Fautrel B; Department of Rheumatology, Flór Ferenc Hospital, Kistarcsa, Hungary.
  • Boonen A; Arthritis Centre,Northwick Park Hospital, Harrow, UK.
RMD Open ; 3(2): e000453, 2017.
Article em En | MEDLINE | ID: mdl-28912960

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 1_ASSA2030 Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Aspecto: Patient_preference Idioma: En Revista: RMD Open Ano de publicação: 2017 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 1_ASSA2030 Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Aspecto: Patient_preference Idioma: En Revista: RMD Open Ano de publicação: 2017 Tipo de documento: Article